What is the Projected CAGR value of the Psychedelic Drugs Market?
Psychedelic Drugs Market is expected to grow at a CAGR of 12.6% during the forecasting period 2023-2030.
Which region controlled the global market during 2023-2030?
North America region Controls the Psychedelic Drugs Market during 2023-2030.
Which is the fastest growing region in the Psychedelic Drugs Market?
Asia Pacific is the fastest growing market share during the forecast period.
Who are the key players in Psychedelic Drugs Market?
Key players are Compass Pathways, MindMed, Hikma Pharmaceuticals, Celon Pharmaceuticals, Cybin Corp, Pfizer Inc., Jazz Pharmaceuticals Inc., Atai Life Sciences N.V., PharmaTher Holdings Ltd, and GH Research PLC.